Engineered antibody helps block SARS-CoV-2 transmission

Researchers at UC Davis Health have engineered a novel antibody, FuG1, that can directly interfere with the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19.

Understanding COVID-19 infection and possible mutations

The binding of a SARS-CoV-2 virus surface protein spike—a projection from the spherical virus particle—to the human cell surface protein ACE2 is the first step to infection that may lead to COVID-19 disease. Penn State ...

Chemists discover the structure of a key coronavirus protein

MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus. This protein, called the envelope protein E, forms a cation-selective channel and plays a key role in the virus's ability to ...

Researchers slash pre-drug screening time from years to days

Researchers at Ben-Gurion University of the Negev (BGU) and The Hebrew University of Jerusalem (HU) have developed a powerful tool that will streamline and accelerate the development of disease therapies, transforming a multi-year ...

page 3 from 9